Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-gated calcium channel alpha(2)delta (α2δ) subunit is an auxiliary protein component of high-voltage-activated (HVA) calcium channels, essential for Ca²⁺ influx into excitable cells. It regulates channel trafficking, surface expression, and biophysical properties. Four isoforms (α2δ-1 to α2δ-4) exist, encoded by CACNA2D1-4. The α2δ subunit influences synaptic function, neurotransmitter release and is implicated in neurological disorders like neuropathic pain and epilepsy. Gabapentinoids target α2δ-1 and α2δ-2 for pain management.
Gabapentinoids bind to the α2δ subunit, reducing calcium influx and neurotransmitter release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel alpha(2)delta subunit (CACNA2D).